Anthem Biosciences Listing Preview: Anthem Biosciences Ltd., which is a fully integrated operations encompassing drug discovery, development, and manufacturing processes, is set to list on BSE and NSE today (Monday, July 21, 2025).
The offer for sale IPO, which opened on July 14 and closed on July 16, has an issue price of Rs 570 per share.
Zee Business managing editor, Anil Singhvi, is expecting a strong listing for the company at an above-Rs 700 price.
The market guru says that the company can list in the range of Rs 715-Rs 730.
Long-term perspective
The market wizard advises applying for good listing gains and long-term with 2-3 years of perspective.
To short-term investors, he advises holding with a stop loss of Rs 675.
Singhvi says that long-term investors must hold the Anthem Biosciences stock in their portfolio.
Anthem Biosciences IPO details
The lot size of the share is 26, while the minimum investment for retail investors is Rs 14,820.Â
The bookbuilding IPO’s tentative allotment of shares was done on July 17, while initiation of funds took place on July 18.
The credit of shares to demat accounts was also done on the same day.
Anthem Biosciences IPO subscription detailsÂ
Qualified institutional buyers subscribed to the IPO by 192.80 times, while non-institutional bidders subscribed by 44.70 times.
Retail investors did it by 5.98 times and employees by 6.99 times.
In total, it was subscribed by 67.42 times.
